Agenda

Friday, September 6

8:30 a.m.: Welcome

8:45 a.m.: Is a Sea change Underway? Less Antiplatelets? More Antithrombotics?
Joaquin Cigarroa, M.D.

9:15 a.m.: Can we Ablate VF?
Samuel Asirvantham

9:45 a.m.: Panel Q & A

10:30 a.m.: With the Low Risk TAVR Trial Outcomes, Who Should Still be Treated with Surgery?
Michael Mack, M.D., F.A.C.C.

11 a.m.: How to make the best of what you have, lessons learned from Transcatheter valve therapies
Firas Zahr, M.D.

11:30 a.m.: Panel Q & A

1 p.m.: The Future of Hypertrophic Cardiomyopathy
Stephen Heitner, M.D.

1:30 p.m.: Cardio-Oncology: Understanding Interplay Between Cancer and Heart Disease for Improved Outcomes
Maros Ferencik, M.D., Ph.D.

2 p.m.: Panel Q & A

2:45 p.m.: Update on Devices for Peripheral Interventions
Ehrin Armstrong, M.D.

3:15 p.m.: Learning from Failure: Novel Approaches to Exercise Training in Heart Failure with Preserved Ejection Fraction
Satyam (Tom) Sarma

3:45 p.m.: Panel Q & A

4:15 p.m.: Treatment of Cardiac Arrhythmias Past and Present and a Glimpse into the Future
Melvin Scheinman, M.D.

Saturday, September 7

8:30 a.m.: The Heart of the Matter: A Preventative Cardiologist's Perspective on Managing Type 2 Diabetes
Mikhail Kosiborod, M.D.

9:00 a.m.: New Treatments for Hypertriglyceridemia
Deepak Bhatt, M.D., M.P.H.

9:30 a.m.: Panel Q & A

10:15 a.m.: The Role of Revascularization in Stable Ischemic Heart Disease
Judith Hochman, M.D., M.A.

10:45 a.m.: Obesity, Inflammation, and Atherosclerosis
Alan Chait, M.D.

11:15 a.m.: Panel Q & A

Speakers

Samuel J. Asirvatham, M.D.
Professor of Medicine and Pediatrics; Division of Pediatric Cardiology and Department of Physiology and Biomedical Engineering; Program Director, Electrophysiology Fellowship Program, Mayo Clinic College of Medicine
 

Ehrin Armstrong, M.D.
Associate Professor, Medicine-Cardiology; Director, Interventional Cardiology; Co-Director, Vascular Laboratory, VA Eastern Colorado Healthcare System
 

Deepak L. Bhatt, M.D., MPH, FACC, FAHA, FSCAI, FESC
Professor of Medicine, Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, Harvard Medical School
 

Alan Chait, M.D.
Edwin L. Bierman Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington
 

Joaquin Cigarroa, M.D.
Head of the Division of Cardiovascular Medicine; Clinical Chief of Knight Cardiovascular Institute; Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University
 

Maros Ferencik, M.D., Ph.D.
Associate Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University
 

Satya (Tom) Sarma, M.D.
Assistant Professor of Internal Medicine, UT Southwestern Medical Center
 

Stephen Heitner, M.D.
Associate Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine, Oregon Health & Science University
 

Judith Hochman, M.D.
Professor of Cardiology; Associate Director, Division of Cardiology, Department of Medicine; Senior Associate Dean for Clinical Sciences; Director, Cardiovascular Clinical Research Center, NYU Langone Health
 

Mikhail Kosiborod, M.D.
Professor of Medicine, University of Missouri-Kansas City School of Medicine, St. Luke’s Health System
 

Michael Mack, M.D., F.A.C.C.
Medical Director, Cardiovascular Surgery, Baylor Health Care System; Chairman of Baylor Scott & White The Heart Hospital, Plano Research Center
 

Melvin Scheinman, M.D.
Professor of Medicine, Walter H. Shorenstein Endowed Chair in Cardiology, Chief of Cardiology Genetrics Arrhythmia Program
 

Firas Zahr, M.D.
Associate Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine; Director of Interventional Cardiology; Co-Director of Complex Heart Valve Program, Oregon Health & Science University